Remove spotlight spotlight-future-generics
article thumbnail

Deep Dive: Communications and Commercialisation

pharmaphorum

This issue assesses European pharma’s approach to strategic communications, the future of pharma commercialisation, communications gaps with patients and, with the pandemic continuing to cast a long shadow over healthcare, how to maximise the effectiveness of HCP engagement. Company Spotlight: The Method.

article thumbnail

Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention

ISPE

Diane concluded by informing the audience that the ISPE Survey on Business Continuity Planning for Drug Shortage Prevention related to generics is still open. Companies interested in participating in the survey can send an email to regulatory@ispe.org.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Are Biologics So Expensive?

BuzzRx

To demonstrate, the biologic drug Humira (generic name adalimumab), which is used to treat autoimmune diseases like rheumatoid arthritis and Crohn’s disease , costs over $6,000 for 1 carton (2 pens) without insurance. It seems unlikely that expensive biologics will get substantially cheaper in the near future.

article thumbnail

Statins PROS and CONS [TOP LIST]

Druggist

In 2019, the availability of high dose statins came into a spotlight again, after the announcement by NHS that statins may be available from pharmacie s without a prescription (NHS, 2019). The above statins may come in generic form or as branded medicines. Availability of high dose statins over the counter. simvastatin. pravastatin.

article thumbnail

American Conference Institute’s Premiere Conference on Life Sciences Antitrust

pharmaphorum

As we proceed through 2021, the spotlight on antitrust activity in the life sciences industry shines brighter than ever. Recent Criminal Generic Price Fixing Cases and How They May Change the Outlook for Competition in the Industry. For several years, state and federal antitrust enforcers in the U.S.

52
article thumbnail

Top Performing Drug – Dupixent (April Edition)

PharmaShots

While the efficacy and safety profile of Dupixent is well-established for atopic dermatitis more broadly, these positive results are the first demonstrating the impact on specific and heavily used areas of the body.”

Dosage 56